Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Ascendis Pharma A/S NasdaqGS:ASND |
13,91 B | 144,29% | 4/6 | 91,21% | 89,80% | 27,83% | UP |
|
ALK-Abelló A/S CPSE:ALK B |
45,60 B | 32,62% | 5/6 | 55,34% | 24,65% | 23,91% | UP |
|
Zealand Pharma A/S CPSE:ZEAL |
21,04 B | 71,10% | 4/6 | -51,93% | 89,62% | 67,79% | DOWN |
|
Bavarian Nordic A/S CPSE:BAVA |
15,11 B | 21,29% | 5/6 | -21,10% | 17,89% | 40,52% | DOWN |
|
BioPorto A/S CPSE:BIOPOR |
0,44 B | -11,13% | 2/4 | 0,00% | 27,36% | -100,00% | DOWN |
|
FluoGuide A/S OM:FLUO |
0,62 B | 0,00% | 2/4 | 0,00% | 0,00% | 95,97% | DOWN |
|
Evaxion A/S NasdaqCM:EVAX |
0,03 B | 0,00% | 0/0 | -47,94% | -149,23% | 168,10% | DOWN |
|
Initiator Pharma A/S OM:INIT |
0,21 B | 0,00% | 2/4 | 0,00% | 0,00% | 208,09% | DOWN |
|
Strategic Partners A/S CPSE:STRAP |
0,03 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
IO Biotech NasdaqGS:IOBT |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | 4260,00% | DOWN |
|
Scandion Oncology A/S BST:8VY |
0,00 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,00% | DOWN |
|
Forward Pharma A/S OTCPK:FWPA.Y |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
